Our results demonstrated that ccRCC patients with positive Dicer expression had more favorable 5-year overall survival and disease specific survival than the ones with negative Dicer expression (P = 0.020 and P = 0.004, respectively; Figure 1D–1E). The gene discussed is DICER1; the disease is nonpapillary renal cell carcinoma.